Medicine & Life Sciences

1. Glioblastoma 100%
2. Glioma 49%
3. Central Nervous System 42%
4. Brain Neoplasms 36%
5. Neoplasms 34%
6. Lymphoma 34%
7. Radiotherapy 29%
8. Temozolomide 24%
9. rindopepimut 21%
10. Therapeutics 21%
11. Radiation 20%
12. Survival 20%
13. Bevacizumab 20%
14. Guidelines 17%
15. Drug Therapy 17%
16. Brain 16%
17. epidermal growth factor receptor VIII 16%
18. Meningioma 14%
19. Neoplasm Metastasis 13%
20. Schwannomatosis 11%
21. Radiosurgery 10%
22. Methotrexate 10%
23. Meningeal Carcinomatosis 10%
24. Neurosurgeons 8%
25. Progression-Free Survival 8%
26. Suprachiasmatic Nucleus 8%
27. Growth 8%
28. Acoustic Neuroma 8%
29. Magnetic Resonance Imaging 7%
30. Genetic Therapy 7%
31. Hematologic Neoplasms 7%
32. Medulloblastoma 7%
33. Stem Cell Transplantation 7%
34. Patient Simulation 7%
35. Standard of Care 7%
36. Parkinsonian Disorders 7%
37. Positron-Emission Tomography 7%
38. Methyltransferases 6%
39. Survivors 6%
40. Anticonvulsants 6%
41. paclitaxel poliglumex 6%
42. Protein-Tyrosine Kinases 6%
43. Steroids 6%
44. Nervous System 6%
45. Isocitrate Dehydrogenase 6%
46. vatalanib 5%
47. Kinetics 5%
48. cediranib 5%
49. Suprachiasmatic Nucleus Neurons 5%
50. fluoromisonidazole 5%